Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A.

PLoS One · 2026 · PMC13020803 · PMID 41886499

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

Strikingly, EA.hy926 cells exhibited a dramatic induction of RASSF1A mRNA, with more than a 200-fold increase relative to control conditions (p < 0.05), while this effect remained highly significant (p < 0.01) when analyzed across replicates.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.